Twin Tree Management, LP Alkermes Plc. Transaction History

Twin Tree Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $24,128 - $30,740	-1,325 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.39 - $22.1 $20,391 - $29,282	1,325 New	1,325 $26,000
Q2 2020 Aug 12, 2020	SELL	$13.31 - $19.41 $13 - $19	-1 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$13.06 - $21.24 $13 - $21	1 New	1 $0
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $98,259 - $123,548	-5,683 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$19.51 - $24.28 $94,779 - $117,952	4,858 Added 588.85%	5,683 $111,000
Q2 2019 Aug 12, 2019	BUY	$21.47 - $37.33 $17,712 - $30,797	825 New	825 $19,000
Q1 2019 May 10, 2019	SELL	$28.4 - $36.49 $31,524 - $40,503	-1,110 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$27.94 - $44.61 $58,981 - $94,171	-2,111 Reduced 65.54%	1,110 $33,000
Q3 2018 Nov 09, 2018	SELL	$38.6 - $46.12 $481,650 - $575,485	-12,478 Reduced 79.48%	3,221 $137,000
Q2 2018 Aug 08, 2018	BUY	$40.56 - $51.36 $636,751 - $806,300	15,699 New	15,699 $646,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.